Hydroxyprogesterone caproate and Stillbirth - a phase IV clinical study of FDA data

Summary:

Stillbirth is reported as a side effect among people who take Hydroxyprogesterone caproate (hydroxyprogesterone caproate), especially for people who are 30-39 old, have been taking the drug for < 1 month and have Foetal exposure during pregnancy.

The phase IV clinical study analyzes which people have Stillbirth when taking Hydroxyprogesterone caproate. It is created by eHealthMe based on reports of 207 people who have side effects when taking Hydroxyprogesterone caproate from the FDA, and is updated regularly.

What is Hydroxyprogesterone caproate?

Hydroxyprogesterone caproate has active ingredients of hydroxyprogesterone caproate. eHealthMe is studying from 211 Hydroxyprogesterone caproate users. Check the latest studies of Hydroxyprogesterone caproate.

What is Stillbirth?

Stillbirth (a birth of dead foetus) is found to be associated with 242 drugs and 450 conditions by eHealthMe. Check the latest studies of Stillbirth.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

207 people reported to have side effects when taking Hydroxyprogesterone caproate.
Among them, 11 people (5.31%) have Stillbirth.

Could Hydroxyprogesterone caproate cause Stillbirth?

Among these 11 people:

How long have people been on Hydroxyprogesterone caproate when they have Stillbirth? *

What is the age of people who have Stillbirth when taking Hydroxyprogesterone caproate? *

What are other side effects people have besides Stillbirth? *

Premature Labor: 1 person, 9.09%
Oedema (fluid collection in tissue): 1 person, 9.09%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 1 person, 9.09%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 9.09%
Amniotic Cavity Infection: 1 person, 9.09%

What are the existing conditions these people have? *

Premature Delivery: 1 person, 9.09%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 1 person, 9.09%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyprogesterone caproate and have Stillbirth?

- Check whether Stillbirth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydroxyprogesterone caproate:

Hydroxyprogesterone caproate (211 reports)

Stillbirth treatments and more:

Stillbirth (6,114 reports)

Browse all side effects of Hydroxyprogesterone caproate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stillbirth:

Stillbirth (242 drugs)

Browse all the conditions that are associated with Stillbirth:

Stillbirth (450 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyprogesterone caproate (the active ingredients of Hydroxyprogesterone caproate) and Hydroxyprogesterone caproate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.